Log In
Print this Print this

Renevia (formerly HyStem-Rx)

  Manage Alerts
Collapse Summary General Information
Company BioTime Inc.
DescriptionBiocompatible, implantable hyaluronan and collagen-based hydrogel cell delivery device
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentPivotal
Standard Indication Transplant (unspecified)
Indication DetailsCell delivery device; Facilitate the stable engraftment of transplanted cells; Treat HIV-related lipoatrophy; Treat the loss of subcutaneous adipose tissue
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today